Concepedia

Haiqin Wang

HW

Statistics

Publications

4

Citations

121

H-Index

4

Active since

2020

Affiliations

Hunan University(Current)

Central South University

Xiangya Hospital Central South University

Haiqin Wang is an author at Hunan University specializing in molecular oncology, multiple myeloma therapy, and multiple myeloma.

ORCID

Publications per year

2020–2022

4

Publications

4

Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma

Hui Yi, Long Liang, Haiqin Wang et al. · Cancer Letters · 2021 · 43 citations

, , +17

Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1

Hui Li, Mridul Roy, Long Liang et al. · Oncogene · 2022 · 38 citations

, , +17

Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway

Haiqin Wang, Yanfei Gong, Long Liang et al. · British Journal of Haematology · 2020 · 21 citations · Full text

, , +17

The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma

Long Liang, Yanjuan He, Haiqin Wang et al. · British Journal of Haematology · 2020 · 19 citations · Full text

, , +17

1–4 of 4